Achilles Therapeutics plc (ACHL)
USD 0.97
(-0.22%)
USD 0.97
(-0.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -48.63 Million | -59.53 Million | -59.28 Million | -25.25 Million | -14.14 Million | -7598.00 |
| Net Income | -69.93 Million | -71.17 Million | -61.09 Million | -33.19 Million | -13.99 Million | -6887.00 |
| Depreciation & Amortization | 4.73 Million | 3.69 Million | 3.28 Million | 772 Thousand | 302 Thousand | 173.00 |
| Deferred income taxes | -15.81 Million | - | 159 Thousand | - | 14 Thousand | - |
| Stock-based compensation | 6.35 Million | 7.02 Million | 6.31 Million | 2.99 Million | 719 Thousand | 76.00 |
| Change in working capital | 10.44 Million | -5.95 Million | -7.93 Million | 3 Million | -1.17 Million | -846.00 |
| Other non-cash items | 15.58 Million | 6.88 Million | -18 Thousand | 1.17 Million | -9000.00 | -114.00 |
| Investing Cash Flow | -1.1 Million | -7.51 Million | -7.63 Million | -11.84 Million | -942 Thousand | -258.00 |
| Investments in PPE | -1.1 Million | -7.51 Million | -7.63 Million | -11.84 Million | -942 Thousand | -258.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -7.51 Million | -7.63 Million | - | - | - |
| Financing Cash Flow | 9.00 | 1000.00 | 160.75 Thousand | 113.7 Million | 93.62 Million | 13.51 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 9034.88 | 1000.00 | 160.73 Million | 114.58 Million | 94 Million | - |
| Other Financing Activities | 9.00 | 1.00 | 160.75 Thousand | -884.49 Thousand | -387.55 Thousand | 13.51 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 257 Thousand | 1.9 Million | -2.57 Million | 5.25 Million | 548 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 10.19 Million | -7.86 Million | -5.35 Million | -2.25 Million | -1.72 Million | -846.00 |
| Cash at beginning of period | 173.33 Million | 266.35 Million | 177.84 Million | 97.59 Million | 10.68 Million | 4981.00 |
| Cash at end of period | 131.53 Million | 173.37 Million | 266.35 Million | 177.84 Million | 97.59 Million | 10.68 Thousand |
| Capital Expenditure | -1.1 Million | -7.51 Million | -7.63 Million | -11.84 Million | -942 Thousand | -258.00 |
| Effect of forex changes on cash | 7.74 Million | -25.93 Million | -5.33 Million | 3.65 Million | 8.37 Million | 47.00 |
| Net cash flow / Change in cash | -41.79 Million | -92.98 Million | 88.5 Million | 80.25 Million | 86.91 Million | 5702.00 |
| Free Cash Flow | -49.74 Million | -67.04 Million | -66.91 Million | -37.09 Million | -15.08 Million | -7856.00 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.38 Thousand | -12.26 Million | -18.79 Million | -69.93 Million | -16.58 Million | -16.84 Thousand |
| Depreciation & Amortization | 1177.00 | 1.17 Million | 1.15 Million | 4.73 Million | 1.19 Million | 1253.00 |
| Deferred income taxes | - | - | -3.71 Million | -15.81 Million | -2.39 Million | - |
| Stock-based compensation | 1312.00 | 1.38 Million | 1.39 Million | 6.35 Million | 1608.00 | 1701.00 |
| Change in working capital | -3037.00 | -7.8 Million | 2 Million | 10.44 Million | 14.88 Million | -2563.00 |
| Other non-cash items | -380.00 | 3.75 Million | 3.71 Million | 15.58 Million | 3.96 Million | -954.00 |
| Investing Cash Flow | -36.00 | -694.6 Thousand | -45.6 Thousand | -1.1 Million | -61.38 Thousand | -537.00 |
| Investments in PPE | -36.00 | -694.6 Thousand | -45.6 Thousand | -1.1 Million | -61.38 Thousand | -537.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 4.42 | 4997.14 | -4.86 | 9.00 | 8033.42 | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.42 | 4997.14 | -4.86 | 9034.88 | 8033.42 | - |
| Other Financing Activities | - | 5.00 | - | 9.00 | 8.00 | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | -1.94 Million | -146 Thousand | 257 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3037.00 | -7.8 Million | 2.15 Million | 10.19 Million | 14.88 Million | -2563.00 |
| Cash at beginning of period | 112.35 Thousand | 131.53 Million | 140.13 Million | 173.33 Million | 143.71 Million | 158.49 Thousand |
| Cash at end of period | 95.16 Thousand | 112.32 Million | 131.53 Million | 131.53 Million | 140.13 Million | 143.74 Thousand |
| Capital Expenditure | -36.00 | -694.6 Thousand | -45.6 Thousand | -1.1 Million | -61.38 Thousand | -537.00 |
| Effect of forex changes on cash | 153.00 | -1.02 Million | 5.63 Million | 7.74 Million | -4520.00 | 3197.00 |
| Net cash flow / Change in cash | -17.19 Thousand | -19.21 Million | -8.59 Million | -41.79 Million | -3.57 Million | -14.74 Thousand |
| Free Cash Flow | -17.34 Thousand | -18.18 Million | -14.27 Million | -49.74 Million | 1.01 Million | -17.94 Thousand |
092780
8946
600875
688009
1777
PAB